Articles From: 2014/3/21 - The King of Ciders? to 2014/3/21 - First Nickel Reports Financial and Operating Results for the Year Ended December 31, 2013


2014/3/21
By Charles Passy, MarketWatch The bottle:Johnny Appleseed hard apple cider The back story: Is hard cider the new craft beer?
Sign-up for 2014/3/21 - The King of Ciders? investment picks
2014/3/21
("Fed 'Stress Test' Results: 29 of 30 Big Banks Could Weather Economic Shock," at 4:15 p.m. ET on March 20 and several subsequent updates that day, contained incorrect numbers for banks' minimum Tier 1 capital ratios.
Sign-up for 2014/3/21 - Correction to Fed 'Stress Test' Stories on Thursday investment picks
2014/3/21
By Sara Sjolin, MarketWatch LONDON (MarketWatch) -- After a week likely to be remembered for Janet Yellen's comments, solid economic data and Ukraine uncertainty, U.S. stock futures on Friday indicated a firmer open on Wall Street and pointed to a strong weekly advance.
Sign-up for 2014/3/21 - UPDATE: Stock futures rise, point to strong weekly gain investment picks
2014/3/21
By Dan Fitzpatrick The Federal Reserve revised its stress-test results for 15 large banks a day after releasing its annual report card, producing a weaker outcome for Bank of America Corp., American Express Co.
Sign-up for 2014/3/21 - Federal Reserve Revises Stress-Test Results -- 2nd Update investment picks
2014/3/21
Positive opinion is based on data from one of the largest clinical registration programs in its class, involving more than 13,000 adults with type 2 diabetes RIDGEFIELD, Conn.
Sign-up for 2014/3/21 - CHMP Recommends Empagliflozin for Approval to Reduce Blood Sugar Levels in Adults with Type 2 Diabetes in Europe investment picks
2014/3/21
Carmanah Technologies Corporation (TSX: CMH) and SOL, Inc., a privately-owned Florida-based company, today jointly announced that Carmanah has entered into a binding Letter of Intent with SOL, Inc. and Michael Sonnenfeldt.
Sign-up for 2014/3/21 - Carmanah Agrees to Purchase SOL Inc. in a Share Exchange Valued at ~$7.5M investment picks
2014/3/21
By Anna Prior Triple-leveraged exchange-traded funds: Just the name sounds scary.
Sign-up for 2014/3/21 - UPDATE: Are leveraged ETFs right for retirees? investment picks
2014/3/21
TSX: BXE CALGARY , March 21, 2014 /PRNewswire/ - Bellatrix Exploration Ltd.
Sign-up for 2014/3/21 - Bellatrix announces adoption of advance notice by-laws investment picks
2014/3/21
http://media.marketwire.com/attachments/201403/73081_pbsholding.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1099967&ProfileId=051205&sourceType=1 DALLAS, TX --
Sign-up for 2014/3/21 - PBS Holding, Inc. (OTCPK: PBHG) Announces the Appointment of New CEO, Board Members and President investment picks
2014/3/21
Liberty Global PLC (LBTYA) filed a Form 8K - Regulation FD Disclosure - with the U.S Securities and Exchange Commission on March 21, 2014.
Sign-up for 2014/3/21 - Liberty Global Files 8K - Regulation FD investment picks
2014/3/21
CN offers conductors' union in Canada one last chance to reach a contract settlement through negotiation; requires upfront union acceptance of binding arbitration if talks fail Canada NewsWire Forward-Looking Statements Certain information included in this news release is "forward-looking statements" within the meaning of the United States Private Securities Litigation Reform Act of 1995 and under Canadian securities laws.
Sign-up for 2014/3/21 - CN offers conductors' union in Canada one last chance to reach a contract settlement through negotiation; requires upfront union acceptance of binding arbitration if talks fail investment picks
2014/3/21
After more than 31 years of service, Antonio Galindez, president and CEO of Dow AgroSciences (DAS), a wholly owned subsidiary of The Dow Chemical Company (NYSE:DOW) will retire from the Company, effective May 1.
Sign-up for 2014/3/21 - Dow AgroSciences’ Galindez to Retire; Hassinger Named New President and CEO investment picks
2014/3/21
Today Biogen Idec (NASDAQ: BIIB) announced that Health Canada has approved ALPROLIX ™ [Coagulation Factor IX (Recombinant), Fc Fusion Protein], for the control and prevention of bleeding episodes and routine prophylaxis in adults, and children aged 12 and older, with hemophilia B.
Sign-up for 2014/3/21 - Health Canada Approves Biogen Idec’s Long-Acting ALPROLIX™ Therapy for Hemophilia B investment picks
2014/3/21
Harvard Apparatus Regenerative Technology, Inc. (NASDAQ:HART), a clinical stage biotechnology company developing regenerated organs for transplant, initially focused on the trachea, was featured in an article published by Fast Company Co.Exist on March 19.
Sign-up for 2014/3/21 - Harvard Apparatus Regenerative Technology Spotlighted by Fast Company Co.Exist investment picks
2014/3/21
Investors should maintain a balanced portfolio that modestly overweights equities, according to Barclays’ latest flagship quarterly research publication Global Outlook: A balanced portfolio still makes sense .
Sign-up for 2014/3/21 - Barclays Advises Investors Maintain a Balanced Portfolio and Hedge for Potential Corrections with Fixed Income investment picks
2014/3/21
WALLDORF, Germany , March 21, 2014 /PRNewswire/ --  SAP AG (NYSE: SAP) today announced that its Annual Report is now available and that SAP's Annual Report on Form 20-F has been filed with the U.S. Securities and Exchange Commission (SEC) for the year ended December 31, 2013 .
Sign-up for 2014/3/21 - SAP Announces Availability of 2013 Annual Report and U.S. Securities and Exchange Commission Filing of Annual Report on Form 20-F investment picks
2014/3/21
U.S. Silver & Gold Inc. announces completed private placement for CDN$6.7 million Canada NewsWire /NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES / TORONTO , March 21, 2014 /CNW/ - U.S. Silver & Gold Inc. (TSX:  USA )(OTCQX: USGIF) ("U.S. Silver & Gold" or the "Company") is pleased to announce that it has closed its previously announced private placement.
Sign-up for 2014/3/21 - U.S. Silver & Gold Inc. announces completed private placement for CDN$6.7 million investment picks
2014/3/21
Progress Software Corporation  (NASDAQ: PRGS), a global software company that simplifies the development, deployment and management of business applications, today announced that it will release financial results for its fiscal first quarter 2014 on Thursday, March 27, 2014.
Sign-up for 2014/3/21 - Progress Software Corporation Announces Details for Fiscal First Quarter 2014 Earnings Release and Conference Call investment picks
2014/3/21
NanoTech Entertainment ( OTCPINK: NTEK ), a pioneer in bringing the 4K Ultra HD experience to consumers, announced today that 4K Studios, a NanoTech subsidiary, has entered into a global distribution agreement with Red Bull Media House .
Sign-up for 2014/3/21 - NanoTech’s UltraFlix 4K IPTV/OTT Streaming Service Adds to Its Sports and Lifestyle 4K Offerings with 12 Red Bull Media House Films investment picks
2014/3/21
American Express Co.
Sign-up for 2014/3/21 - American Express CEO Awarded $24.4 Million for 2013 investment picks
2014/3/21
By Myra P.
Sign-up for 2014/3/21 - UPDATE: Oil tallies gains for the day and the week investment picks
2014/3/21
The Cavanal Hill Funds announced today that its funds have once again been honored by the Thomson Reuters Awards of Excellence with Lipper Fund Awards, as well as three number one Lipper rankings.
Sign-up for 2014/3/21 - Cavanal Hill Funds Receive Lipper Fund Awards for the Third Straight Year investment picks
2014/3/21
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1100092&ProfileId=051205&sourceType=1 JERSEY, CHANNEL ISLANDS --
Sign-up for 2014/3/21 - Grant of awards investment picks
2014/3/21
DALLAS , March 21, 2014 /PRNewswire/ -- Permian Basin Royalty Trust (NYSE: PBT) ("Permian") today declared a cash distribution to the holders of its units of beneficial interest of $0.108529 per unit, payable on April 14, 2014 , to unit holders of record on March 31, 2014 .
Sign-up for 2014/3/21 - Permian Basin Royalty Trust Announces March Cash Distribution investment picks
2014/3/21
Genzyme, a Sanofi company (EURONEXT: SAN and NYSE: SNY), announced today that Brazil’s national health surveillance agency, ANVISA, has approved Lemtrada (alemtuzumab) for the treatment of patients with relapsing forms of multiple sclerosis (MS) to slow or reverse the accumulation of physical disability and reduce the frequency of clinical exacerbations.
Sign-up for 2014/3/21 - Genzyme’s Lemtrada™ Approved in Brazil for Treatment of Multiple Sclerosis investment picks
2014/3/21
By Claudia Assis, MarketWatch SAN FRANCISCO (MarketWatch) -- Shares of Plug Power Inc. fell 9% on Friday, and the stock was moving toward ending the week down nearly 20% as investors' enthusiasm for it seemed to have dried up -- at least for now.
Sign-up for 2014/3/21 - More weekly losses for Plug Power, fuel-cell stocks investment picks
2014/3/21
By Lukas I.
Sign-up for 2014/3/21 - Putin Says Russia Should Refrain From More Retaliation Against U.S. investment picks
2014/3/21
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0934701001&sourceType=1 http://media3.marketwire.com/logos/20120424-FNI200.jpg TORONTO, ONTARIO --
Sign-up for 2014/3/21 - First Nickel Reports Financial and Operating Results for the Year Ended December 31, 2013 investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: 2014/3/21 - The King of Ciders? to 2014/3/21 - First Nickel Reports Financial and Operating Results for the Year Ended December 31, 2013
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity